Johnson & Johnson Starts Late-Stage Coronavirus Vaccine Clinical Trial
The phase 3 study of JNJ-78436735, which will enroll 60,000 participants, is underway.
Full Article
Johnson & Johnson Starts Late-Stage Coronavirus Vaccine Clinical Trial
Motley Fool
0 shares
1 views
You might like
Related news coverage
What's It Like To Volunteer In A COVID-19 Vaccine Trial?
Newsy
Watch Video"It was not my intent to be involved at all, ever."
Bonnie Blue is Chicago's first COVID-19 vaccine..
-
Dow ends 400+ points up in reversal of last week's selloff
Proactive Investors
-
Wall Street looking strong to open the week
Proactive Investors
-
Wall Street rises at the opening bell
Proactive Investors
-
Covid: J&J vaccine shows strong immune response
IndiaTimes
Advertisement
More coverage
It’s Not Vaccine Nationalism, It’s Vaccine Idiocy – OpEd
Eurasia Review
Last week an official with China’s Center for Disease Control and Prevention (CDC) said that the country may have a vaccine..
